Students from Saint Joseph's University reflect on their experience attending the FiercePharma conference: Julia Haciski: junior majoring in Pharmaceutical & Healthcare BusinessMady Hubbard: junior majoring in Pharmaceutical & Healthcare BusinessSofia Musaallam: junior majoring in Pharmaceutical & Healthcare BusinessJacklyn Capasso: senior majoring in Pharmaceutical & Healthcare Business as well as Business Intelligence & AnalyticsYara Memar: sophomore majoring in Pharmaceutical & Healthcare BusinessGrace Rudder: senior majoring in Pharmaceutical & Healthcare BusinessMarlene Chmielewski: MBA student with concentrations in Pharmaceutical & Healthcare Business as well as Marketing The podcast series' ongoing co-host is Jon Evoy. He is a healthcare / pharmaceutical marketer who also is a Pharma Adjunct Professor. Classes he's taught include healthcare marketing, pharmaceutical market research, pharmaceutical sales, & healthcare supply chain. Dr. Thani Jambulingam is the Dirk (Dick) Warren ’50 Sesquicentennial Chair and Professor of Pharmaceutical and Healthcare Business at Saint Joseph’s University’s Haub School of Business. With nearly three decades in academia, he brings interdisciplinary expertise in pharmaceutical strategy, healthcare economics, innovation, and public policy. His research explores how pharmaceutical innovation, business strategies, and healthcare policies create value for patients, organizations, and society, focusing on competition, drug pricing, market access, healthcare intermediaries, supply chains, and barriers to medical innovation.Dr. Jambulingam contributes to national policy discussions through research and publications in Health Affairs Forefront, Pharmaceutical Executive, and Pharmaceutical Commerce. Recent work examines Medicare drug policy, GLP-1 therapies, pharmacy benefit manager reform, healthcare affordability, and pharmaceutical spending’s relationship to patient outcomes.An award-winning educator and researcher, he integrates industry developments, real-world challenges, and analytics into courses on pharmaceutical marketing, healthcare strategy, market research, business analytics, and artificial intelligence for managerial decision-making.He has served in academic leadership roles, including eight years as department chair, and reviews for leading journals in pharmaceutical sciences, marketing, and management. His mission is to advance healthcare strategies and policies that improve patient access, strengthen system performance, and ensure medical innovation delivers measurable value.